Related Experiment Videos
Paracoccidioidomycosis: case report and review
B J Manns1, B W Baylis, S J Urbanski
1Department of Internal Medicine, Foothills Medical Center, Alberta, Canada.
Summary
Paracoccidioidomycosis is a fungal infection that can be difficult to diagnose and treat, even with standard therapies. Early suspicion in patients with relevant travel history and specific symptoms is crucial for effective management.
Area of Science:
- Mycology
- Infectious Diseases
- Tropical Medicine
Background:
- Paracoccidioidomycosis is a systemic fungal infection endemic to Latin America.
- Diagnosis and treatment can be challenging, particularly in non-endemic regions or with atypical presentations.
Observation:
- A 59-year-old man presented with paracoccidioidomycosis 15 years after leaving South America.
- The patient exhibited resistance to conventional treatments, including itraconazole, amphotericin B, and sulfadiazine.
- He ultimately succumbed to recurrent arterial emboli, potentially linked to paracoccidioidomycotic aortitis.
Findings:
- This case highlights diagnostic and therapeutic challenges associated with paracoccidioidomycosis.
- Key indicators for suspicion include relevant travel history, weight loss, and pulmonary, mucosal, or cutaneous lesions.
- Imidazole antifungal medications are a key therapeutic option.
Implications:
- Clinicians should consider paracoccidioidomycosis in patients with compatible symptoms and travel history.
- Prompt and accurate diagnosis is vital for effective management and improved patient outcomes.
- Further research into optimal therapeutic strategies for refractory cases is warranted.